Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (61)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chen, H.
Right arrow Articles by Eastmond, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.
Right arrow Articles by Eastmond, D. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

other

Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects

Hongwei Chen 1 and David A. Eastmond 2

Environmental Toxicology Graduate Program, Department of Entomology, University of California Riverside, California 92521, USA

2To whom correspondence should be addressed

Exposure to benzene, a human and animal carcinogen, results in the formation of structural chromosomal aberrations in the bone marrow and blood cells of animals and humans. The mechanisms underlying these clastogenic effects are unknown. Inhibition of enzymes involved in DNA replication and repair, such as topoisomerase enzymes, by the metabolites of benzene represents a potential mechanism for the formation of chromosomal aberrations. To test this hypothesis, the inhibitory effects of various phenolic and qulnone metabolites of benzene on the activity of human topoisomerases I and II were studied in vitro. No inhibition of topolsomerase I was seen with any of the tested metabolites. Inhibitory effects on topoisomerase II were not observed for hydroqulnone, phenol, 2,2'-biphenol, 4,4'-biphenol and catechol at concentrations as high as 500 µM. 1,4-Benzoquinone and 1,2,4-benzenetrlol inhibited topoisomerase II at relatively high 500 and 250 µM concentrations, respectively. However following bioactlvation using a peroxldase/H2O2 system, Inhibitory effects were seen at concentrations as low as 50 µM for both phenol and 2,2'-biphenol and 10 µM for 4,4'-biphenol. The addition of reduced glutathione (GSH) to the 4,4'-biphenol and horseradish peroxidase reaction system protected topoiso merase II from inhibition suggesting that diphenoquinone or another oxidation product formed from 4,4'-biphenol might be the reactive species. These in vitro results indicate that inhibition of topolsomerase II may contribute to the clastogenic and carcinogenic effects of benzene. In addition, metabolites formed from these phenolic compounds appear to represent several new types of topolsomerase II-Inhibiting compounds.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anticancer ResHome page
Y. MURAKAMI, H. ISHII, S. HOSHINA, N. TAKADA, A. UEKI, S. TANAKA, Y. KADOMA, S. ITO, M. MACHINO, and S. FUJISAWA
Antioxidant and Cyclooxygenase-2-inhibiting Activity of 4,4'-Biphenol, 2,2'-Biphenol and Phenol
Anticancer Res, June 1, 2009; 29(6): 2403 - 2410.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
S Wilbur, D Wohlers, S Paikoff, L. Keith, and O Faroon
ATSDR evaluation of health effects of benzene and relevance to public health
Toxicology and Industrial Health, June 1, 2008; 24(5-6): 263 - 398.
[Abstract] [PDF]


Home page
BloodHome page
M. T. Smith, Y. Wang, C. F. Skibola, D. J. Slater, L. L. Nigro, P. C. Nowell, B. J. Lange, and C. A. Felix
Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children
Blood, December 15, 2002; 100(13): 4590 - 4593.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. J. Raffini, D. J. Slater, E. F. Rappaport, L. Lo Nigro, N.-K. V. Cheung, J. A. Biegel, P. C. Nowell, B. J. Lange, and C. A. Felix
Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6
PNAS, April 2, 2002; 99(7): 4568 - 4573.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
F. Marcon, A. Zijno, G. Dobrowolny, A. Carere, and R. Crebelli
Detection of 1cen-1q12 lesions in different phases of the cell cycle: dual colour FISH analysis of peripheral lymphocytes from subjects with occupational exposure to petroleum fuels
Mutagenesis, March 1, 2002; 17(2): 157 - 162.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. K. Baker, E. U. Kurz, D. W. Pyatt, R. D. Irons, and D. J. Kroll
Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase II{alpha}
Blood, August 1, 2001; 98(3): 830 - 833.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. L. Wiemels, A. Pagnamenta, G. M. Taylor, O. B. Eden, F. E. Alexander, and M. F. Greaves
A Lack of a Functional NAD(P)H:Quinone Oxidoreductase Allele Is Selectively Associated with Pediatric Leukemias That Have MLL Fusions
Cancer Res., August 1, 1999; 59(16): 4095 - 4099.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
G. L. Gist and J. R. Burg
Benzene--a Review of the Literature from a Health Effects Perspective
Toxicology and Industrial Health, November 1, 1997; 13(6): 661 - 714.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. H. Schiestl, J. Aubrecht, F. Khogali, and N. Carls
Carcinogens induce reversion of the mouse pink-eyed unstable mutation
PNAS, April 29, 1997; 94(9): 4576 - 4581.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.